Trial Profile
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Trientine (Primary)
- Indications Hepatolenticular degeneration
- Focus Pharmacodynamics
- 13 Jul 2018 According to a Bausch Health Companies media release, Valeant Pharmaceuticals International changed its name to Bausch Health Companies.
- 21 Nov 2011 New trial record